WVE
Wave Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$3.17
+1.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 26.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.38x
- Price / sales
- 9.56x
- Price / cash flow
- -3.39x
Enterprise value
- Enterprise value
- $178.2M
- EV / sales
- 2.73x
- EV / EBITDA
- -0.90x
- EV / EBIT
- -0.82x
- Market cap
- $625.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026